Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisy.

Autor: Titov KS; NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. ks-titov@mail.ru, Kiselevskii MV, Demidov LV, Mikhailova IN, Shubina IZh, Rodionova LM, Sinel'nikov IE, Topol' KY, Gritsai AN
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2009 Nov; Vol. 148 (5), pp. 794-6.
DOI: 10.1007/s10517-010-0818-2
Abstrakt: Clinical efficiency of low dose Roncoleukin was studied in 30 patients with metastatic exudative pleurisy. Intrapleural therapy proved to be highly effective (overall effect reached 84%), was well tolerated, and improved patients' quality of life.
Databáze: MEDLINE